December 09, 2021 at 05:15PM Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Booster Dose to 16- and 17-Year-Olds

The FDA amended the emergency use authorizations for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for administration to individuals 16 and 17 years of age at least six months after completion of primary vaccination with the Pfizer-BioNTech COVID-19 Vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3IDHw2I